Autori: Jurczyszyn Artur
Naslov | Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy (Meeting Abstract) |
Autori | Mateos Maria-Victoria Szarejko Monika Bila Jelena S ![]() |
Info | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, (2023), vol. 23 br. , Suppl. 2, str. S200-S201 |
Ispravka | Web of Science Elečas Rang časopisa |
|